HeartCore Enterprises, Inc. - 10-Q Summary (Q2 2025)
Business Context and Reporting Period
This summary covers the quarterly period ended June 30, 2025. HeartCore Enterprises, Inc. (HTCR) is a software development and consulting company headquartered in Tokyo, Japan, with operations in the U.S., Vietnam, and the Netherlands. The company operates through two primary divisions: Customer Experience Management (CXM) and Digital Transformation (DX), alongside a "GO IPO" consulting business assisting Japanese companies with U.S. listings. The company is classified as a smaller reporting company and an emerging growth company.
Key Financial Metrics
| Metric | Q2 2025 (3 Months) | Q2 2024 (3 Months) | YTD 2025 (6 Months) | YTD 2024 (6 Months) |
|---|---|---|---|---|
| Revenues | $4,744,246 | $4,066,388 | $8,331,272 | $9,113,120 |
| Gross Profit | $2,217,595 | $805,881 | $3,317,879 | $2,838,070 |
| Gross Margin | 46.7% | 19.8% | 39.8% | 31.1% |
| Net Income (Loss) | $1,061,506 | $(2,211,118) | $(2,075,875) | $(3,689,120) |
| Net Income (Loss) to Common Shareholders | $1,099,291 | $(1,951,100) | $(1,987,701) | $(3,284,450) |
| Cash and Cash Equivalents | $2,347,622 | $2,121,089 (Dec 31, 2024) | $2,347,622 | $3,806,349 (Dec 31, 2024) |
| Total Debt (Current + Non-Current) | $1,490,664 | $1,652,068 (Dec 31, 2024) | $1,490,664 | $1,652,068 (Dec 31, 2024) |
Material Changes vs. Prior Period
- Profitability Turnaround (Q2): The company reported a net income of $1.06 million for Q2 2025, a significant improvement from a net loss of $2.21 million in Q2 2024. This was driven by a 175% increase in gross profit and a shift from operating loss to operating income.
- Revenue Mix Shift: Q2 revenue increased 16.7% year-over-year, primarily due to a $1.16 million increase in on-premise software sales (large CMS license orders). Conversely, revenue from customized software development and consulting services declined due to market competition and strategic shifts.
- Cost Efficiency: Cost of revenues decreased 22.5% in Q2, attributed to reduced subcontracting costs and improved operational efficiency in IPO consulting. General and administrative expenses dropped 22.7% due to the full impairment of intangible assets from the Sigmaways acquisition in late 2024, eliminating amortization expenses.
- YTD Performance: Despite the strong Q2, the company reported a net loss of $2.08 million for the six months ended June 30, 2025, compared to a $3.69 million loss in the same period in 2024. YTD revenue decreased 8.6% due to a slowdown in the first half of the year.
- Investment Volatility: Other income/expense fluctuated significantly due to changes in the fair value of marketable securities and warrants. Q2 saw a $950k gain in other income, while YTD resulted in an $886k expense.
Guidance, Outlook, Risks, and Unusual Items
- Nasdaq Compliance Risks: The company received notices of non-compliance with Nasdaq listing rules regarding the Minimum Bid Price (Rule 5550(a)(2)) and Minimum Stockholders' Equity (Rule 5550(b)).
- Bid Price: Granted 180 days (until Nov 3, 2025) to regain compliance.
- Equity: Granted an extension until September 30, 2025, to regain compliance, contingent on completing transactions under new equity agreements.
- Capital Raising Activities: On June 30, 2025, the company entered into an Equity Purchase Agreement (ELOC) with Crom Structured Opportunities Fund I, LP, allowing for up to $25 million in share purchases. Concurrently, the company issued 2,000 shares of Series A Convertible Preferred Stock for $2 million and 750,000 common shares as commitment fees.
- Subsequent Event - Asset Sale: On July 24, 2025, the Board approved a non-binding letter of intent to sell 100% of HeartCore Japan (its primary operating subsidiary) for approximately $12 million in cash.
- Internal Controls: Management concluded that disclosure controls and procedures were not effective as of June 30, 2025, citing reasons previously disclosed in the 2024 10-K.
- Customer Concentration: Customer B accounted for 17.6% of Q2 2025 revenue and 23.4% of total accounts receivable as of June 30, 2025.
Investor Verification Checklist
- Nasdaq Compliance Status: Verify if the company successfully regains compliance with the $1.00 minimum bid price and $2.5 million stockholders' equity requirements by the September 30, 2025 deadline.
- HeartCore Japan Sale: Monitor the progress of the proposed $12 million sale of HeartCore Japan, including regulatory approvals and closing conditions.
- Equity Dilution: Assess the potential dilution from the $25 million Equity Purchase Agreement (ELOC) and the conversion of Series A Preferred Stock.
- Revenue Sustainability: Evaluate whether the Q2 revenue spike from large on-premise software orders is sustainable or a one-time event, given the decline in recurring service revenue.
- Internal Control Remediation: Review the company's plan to remediate the material weaknesses in internal controls over financial reporting.